Sign in

CIK 0001682852

  • Large accelerated filer

Moderna, Inc.

Sign in to watch
Ticker
MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813467528
Phone
+1 617-714-6500
Business address
325 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
Moderna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$50,775,837
in 5 filings, $50.8M under 10b5-1 plans

Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-29 Mock James M Chief Financial Officer Sale 10b5-1 −183 $144.50 $26K 5,871
2024-05-29 Klinger Shannon Thyme Chief Legal Officer Sale 10b5-1 −183 $144.50 $26K 10,768
2024-05-29 Hoge Stephen President Sale 10b5-1 −341 $144.50 $49K 1,471,777
2024-05-28 Mock James M Chief Financial Officer Exercise or conversion 10b5-1 +328 6,054
2024-05-28 Mock James M Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −328 3,617
2024-05-28 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion 10b5-1 +328 10,951
2024-05-28 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion · Restricted Stock Units 10b5-1 −328 3,617
2024-05-28 Hoge Stephen President Exercise or conversion 10b5-1 +610 1,472,118
2024-05-28 Hoge Stephen President Exercise or conversion · Restricted Stock Units 10b5-1 −610 6,716
2024-05-28 Mock James M Chief Financial Officer Sale 10b5-1 −648 $162.47 $105K 5,726
2024-05-28 Klinger Shannon Thyme Chief Legal Officer Sale 10b5-1 −1,296 $162.47 $211K 10,623
2024-05-24 Mock James M Chief Financial Officer Exercise or conversion 10b5-1 +1,326 6,374
2024-05-24 Mock James M Chief Financial Officer Exercise or conversion · Restricted Stock Units 10b5-1 −1,326 3,978
2024-05-24 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion 10b5-1 +2,652 11,919
2024-05-24 Klinger Shannon Thyme Chief Legal Officer Exercise or conversion · Restricted Stock Units 10b5-1 −2,652 7,957
2024-05-22 AFEYAN NOUBAR Director Sale 10b5-1 −100 $142.95 $14K 1,996,831
2024-05-22 AFEYAN NOUBAR Director Sale 10b5-1 −200 $144.40 $29K 1,996,631
2024-05-22 AFEYAN NOUBAR Director Sale 10b5-1 −100 $145.03 $15K 1,996,531
2024-05-22 AFEYAN NOUBAR Director Sale 10b5-1 −300 $147.06 $44K 1,996,231
2024-05-22 AFEYAN NOUBAR Director Sale 10b5-1 −600 $148.21 $89K 1,995,631

Page 29 of 38 · 743 trades